2seventy bio, Inc.
TSVT
$4.95
$2.1576.79%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/12/2025
-
GuruFocus
3/12/2025
-
Business Wire
3/11/2025
-
GuruFocus
3/11/2025
-
PR Newswire
3/11/2025
-
Stock Options Channel
3/11/2025
-
Benzinga
3/11/2025
-
GuruFocus
3/11/2025
-
The Fly
3/11/2025
-
Business Wire
3/11/2025
-
The Fly
3/11/2025
-
MarketBeat
3/11/2025
-
TipRanks Financial Blog
3/11/2025
-
The Fly
3/11/2025
-
Seeking Alpha - Healthcare
3/11/2025
-
GuruFocus
3/11/2025
-
Business Wire
3/10/2025
-
MarketBeat
3/8/2025
-
MarketBeat
2/25/2025
-
GuruFocus
2/25/2025
-
Business Wire
2/25/2025
-
MarketBeat
2/20/2025
-
MarketBeat
2/14/2025
-
MarketBeat
2/6/2025
-
GuruFocus
2/6/2025
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 12, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 675 7270
Address
60 Binney Street
Cambridge, MA 02142
Cambridge, MA 02142
Country
Year Founded
Business Description
Sector
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company’s products pipeline...
more
